Mountain Valley MD Holdings Inc. (MVMDF)

USD 0.02

(0.0%)

Market Cap (In USD)

6.16 Million

Revenue (In USD)

60 Thousand

Net Income (In USD)

-7.67 Million

Avg. Volume

81.96 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.0131-0.06
PE
-
EPS
-
Beta Value
0.899
ISIN
CA62430M1014
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Dennis Hancock
Employee Count
-
Website
https://www.mountainvalleymd.com
Ipo Date
2020-05-19
Details
Mountain Valley MD Holdings Inc., through its subsidiary, Mountain Valley MD Inc., operates as a health and wellness company. The company engages in the implementation and licensing of its technologies to pharmaceutical, vaccine, and nutraceutical third parties. It offers Quicksome oral drug formulation and delivery technologies; Quicksol solubility formulation technology; and dose sparing adjuvant. In addition, the company is developing IM032 for the treatment of male beagle dogs for comparing intramuscular and subcutaneous dosing. Mountain Valley MD Holdings Inc. is headquartered in Concord, Canada.